| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | 1.63e-06 | 493 | 41 | 7 | 15368895 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TATDN3 LRP5 RNF213 SEMA4D RASEF PPARA WDR11 PRPF3 CDC42BPB DNAH1 | 6.68e-06 | 1489 | 41 | 10 | 28611215 |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 14500732 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 18187866 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 21285357 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 17171436 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 17507929 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.26e-05 | 1353 | 41 | 9 | 29467282 | |
| Pubmed | 2.68e-05 | 300 | 41 | 5 | 28561026 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 38280375 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 12475935 | ||
| Pubmed | 4.11e-05 | 163 | 41 | 4 | 24316575 | ||
| Pubmed | 4.72e-05 | 1139 | 41 | 8 | 36417873 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 33643786 | ||
| Pubmed | GPR120 controls neonatal brown adipose tissue thermogenic induction. | 6.07e-05 | 10 | 41 | 2 | 31361546 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.84e-05 | 1201 | 41 | 8 | 35696571 | |
| Pubmed | 7.93e-05 | 615 | 41 | 6 | 31048545 | ||
| Pubmed | 8.58e-05 | 197 | 41 | 4 | 32434143 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 9.40e-05 | 1257 | 41 | 8 | 36526897 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 9.78e-05 | 639 | 41 | 6 | 23443559 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 21045808 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.34e-04 | 221 | 41 | 4 | 29991511 | |
| Pubmed | 1.38e-04 | 223 | 41 | 4 | 20020773 | ||
| Pubmed | 1.38e-04 | 223 | 41 | 4 | 33731348 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 22154759 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.79e-04 | 714 | 41 | 6 | 28302793 | |
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 34752747 | ||
| Pubmed | Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. | 1.82e-04 | 17 | 41 | 2 | 21653943 | |
| Pubmed | 1.98e-04 | 245 | 41 | 4 | 21182205 | ||
| Pubmed | 2.01e-04 | 730 | 41 | 6 | 34857952 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.05e-04 | 462 | 41 | 5 | 31138677 | |
| Pubmed | USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. | 2.05e-04 | 18 | 41 | 2 | 17846119 | |
| Pubmed | 2.17e-04 | 251 | 41 | 4 | 28077445 | ||
| Pubmed | 2.34e-04 | 101 | 41 | 3 | 10997877 | ||
| Pubmed | 2.40e-04 | 754 | 41 | 6 | 35906200 | ||
| Pubmed | 2.41e-04 | 102 | 41 | 3 | 26584622 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 18669648 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.55e-04 | 104 | 41 | 3 | 31240132 | |
| Pubmed | 2.78e-04 | 494 | 41 | 5 | 26831064 | ||
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 37422473 | ||
| Pubmed | 2.82e-04 | 777 | 41 | 6 | 35844135 | ||
| Pubmed | 3.34e-04 | 281 | 41 | 4 | 26725010 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 3.45e-04 | 807 | 41 | 6 | 30575818 | |
| Pubmed | 3.94e-04 | 533 | 41 | 5 | 25544563 | ||
| Pubmed | 3.98e-04 | 121 | 41 | 3 | 34029587 | ||
| Pubmed | 4.33e-04 | 26 | 41 | 2 | 31138536 | ||
| Pubmed | 4.67e-04 | 27 | 41 | 2 | 11401437 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 4.86e-04 | 558 | 41 | 5 | 27591049 | |
| Pubmed | 5.39e-04 | 29 | 41 | 2 | 28364022 | ||
| Pubmed | 5.83e-04 | 138 | 41 | 3 | 30320910 | ||
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 6.74e-04 | 145 | 41 | 3 | 27049334 | |
| Pubmed | 7.37e-04 | 347 | 41 | 4 | 17114649 | ||
| Pubmed | Efficient isolation of novel mouse genes differentially expressed in early postimplantation embryos. | 7.43e-04 | 34 | 41 | 2 | 7490078 | |
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 22325351 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 8.08e-04 | 949 | 41 | 6 | 36574265 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 8.16e-04 | 626 | 41 | 5 | 33644029 | |
| Pubmed | 8.33e-04 | 156 | 41 | 3 | 32850835 | ||
| Pubmed | 9.10e-04 | 971 | 41 | 6 | 33306668 | ||
| Pubmed | 9.85e-04 | 653 | 41 | 5 | 22586326 | ||
| Pubmed | 9.98e-04 | 655 | 41 | 5 | 35819319 | ||
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 1.07e-03 | 384 | 41 | 4 | 31059266 | |
| Pubmed | PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. | 1.08e-03 | 41 | 41 | 2 | 22325352 | |
| Pubmed | 1.14e-03 | 390 | 41 | 4 | 17643375 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.16e-03 | 678 | 41 | 5 | 30209976 | |
| Interaction | H2BC17 interactions | 8.15e-06 | 140 | 40 | 5 | int:H2BC17 | |
| Interaction | PRKRA interactions | 1.22e-05 | 400 | 40 | 7 | int:PRKRA | |
| Interaction | NCAPH interactions | 3.41e-05 | 315 | 40 | 6 | int:NCAPH | |
| Interaction | RPS2 interactions | 3.73e-05 | 657 | 40 | 8 | int:RPS2 | |
| Interaction | RPS6 interactions | 4.23e-05 | 874 | 40 | 9 | int:RPS6 | |
| Interaction | H1-1 interactions | 5.55e-05 | 507 | 40 | 7 | int:H1-1 | |
| Interaction | RPL3 interactions | 7.26e-05 | 722 | 40 | 8 | int:RPL3 | |
| Interaction | RPS4X interactions | 8.25e-05 | 540 | 40 | 7 | int:RPS4X | |
| Interaction | USP15 interactions | 8.84e-05 | 546 | 40 | 7 | int:USP15 | |
| Interaction | SMTN interactions | 9.07e-05 | 44 | 40 | 3 | int:SMTN | |
| Interaction | DGCR8 interactions | 1.12e-04 | 242 | 40 | 5 | int:DGCR8 | |
| Cytoband | 14q32.3 | 3.49e-05 | 10 | 41 | 2 | 14q32.3 | |
| Cytoband | 9q34 | 1.08e-03 | 54 | 41 | 2 | 9q34 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.79e-04 | 13 | 28 | 2 | 685 | |
| GeneFamily | L ribosomal proteins | 2.81e-03 | 51 | 28 | 2 | 729 | |
| ToppCell | severe-Lymphocytic-B_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.55e-05 | 164 | 41 | 4 | a1031e9f945a15186ee14c12be47aa11c3c6583b | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.09e-05 | 177 | 41 | 4 | 605f71515c877bb4de4121675ec8c1318a2500a7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | Severe-Myeloid-Macrophages-|Severe / Condition, Lineage, Cell class and cell subclass | 2.71e-05 | 189 | 41 | 4 | 769b52073a0f0543a72e9f32772321194b70cb2f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 193 | 41 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | (3)_B_T_doublet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.00e-05 | 194 | 41 | 4 | be0df16ef80567511bcde1636f0f5cf7634f03d2 | |
| ToppCell | (3)_B_T_doublet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.00e-05 | 194 | 41 | 4 | b5ce292c4cb940e9ddde7c255274f985f654645f | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | e74cd8cf3763f6adbfd1c269a886a806049714cf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 194 | 41 | 4 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.12e-05 | 196 | 41 | 4 | 64b23d819efddb25024c86f2e1b5dc4159337ddd | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.12e-05 | 196 | 41 | 4 | ba46f80d1497eaf4d71b59504106ba4b84e4ff9f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 196 | 41 | 4 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.12e-05 | 196 | 41 | 4 | eb0b711ca6da7b5e5313791c3c3985358e2a222e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 196 | 41 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.24e-05 | 198 | 41 | 4 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 118 | 41 | 3 | c351e465ece4f3767b2c19e695eca3c263c68777 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-04 | 143 | 41 | 3 | 5c81b238be53f010d691d0c59c1c29cb52222ed3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-04 | 143 | 41 | 3 | b74571d30def54a0524c8d95a3bc9d3439319eb4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.53e-04 | 150 | 41 | 3 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.60e-04 | 151 | 41 | 3 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.60e-04 | 151 | 41 | 3 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-MAIT|Leuk-UTI / Disease, Lineage and Cell Type | 3.74e-04 | 153 | 41 | 3 | ac3a1d1b5bf6009df818fd757dad7382d95c60dc | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-04 | 154 | 41 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-04 | 154 | 41 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 155 | 41 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 155 | 41 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.96e-04 | 156 | 41 | 3 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 158 | 41 | 3 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.18e-04 | 159 | 41 | 3 | 299e2162a82e31196d7f3a110c2db622349edfff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.18e-04 | 159 | 41 | 3 | 0a3a363b30a8c741e1a3e2525725108d03c21776 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 160 | 41 | 3 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.26e-04 | 160 | 41 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 160 | 41 | 3 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 160 | 41 | 3 | 4738d0c73d8c3508e5b5beb6c61e0ad551d9b949 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 160 | 41 | 3 | 0b8151037b28f52a21918856a1e9336e8d5edb90 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.26e-04 | 160 | 41 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD8+_T|normal_Lung / Location, Cell class and cell subclass | 4.26e-04 | 160 | 41 | 3 | 97a4c69824e8708fbb12c468be1828d24a111db3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-04 | 166 | 41 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 4.74e-04 | 166 | 41 | 3 | 9788486582cc2c5f28b9ea015e235732f9fefb1e | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.83e-04 | 167 | 41 | 3 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-04 | 169 | 41 | 3 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | LAM-Lymphoid-B-cell-1|LAM / Condition, Lineage and Cell class | 5.08e-04 | 170 | 41 | 3 | 2b822a95a8d7ee193d40231418d6bd4cf9662842 | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_intermediate|ICU-SEP / Disease, Lineage and Cell Type | 5.17e-04 | 171 | 41 | 3 | 2e44bf6f3d90193e7cadcac48bb852bd632a81bc | |
| ToppCell | URO-Myeloid-cDC1|URO / Disease, Lineage and Cell Type | 5.35e-04 | 173 | 41 | 3 | 57f4e9f39ef6e02dca76f3dd0b39a0871917ed5a | |
| ToppCell | critical-Myeloid-pDC|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.35e-04 | 173 | 41 | 3 | e8508c3efbe0f0fae51484a5535d43103c810d4e | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | 80a47e6ab6125f4f2ac1ad5ceac7801c6ebfa8ca | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | 27fc4bf8a2df2a43175443ebb63f607afec6483d | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.44e-04 | 174 | 41 | 3 | 263e6d9c3d59ffc1e88baa1fd20b8c0e5be46ffa | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_TEM|IIF / Disease, Lineage and Cell Type | 5.53e-04 | 175 | 41 | 3 | 0e7cde3bd638ab85abe915d40c432123f92af4fc | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-04 | 177 | 41 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | NS-critical-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.72e-04 | 177 | 41 | 3 | bbea488582f1eb863950c660afed9159630f6960 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-04 | 177 | 41 | 3 | d5503605d46a335cc7ca1f94626809f9e1b505e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-04 | 178 | 41 | 3 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD8_TCM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.81e-04 | 178 | 41 | 3 | cecfda3625e6f9d9bfe47a147efddb63fa3be6df | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.81e-04 | 178 | 41 | 3 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-04 | 178 | 41 | 3 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-04 | 178 | 41 | 3 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.91e-04 | 179 | 41 | 3 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | NS-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.91e-04 | 179 | 41 | 3 | c044478525b8e7eedecddb924c1b049331180cb2 | |
| ToppCell | droplet-Limb_Muscle-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-04 | 179 | 41 | 3 | 013818e173101efca7625ccd4258e60655815d73 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-04 | 180 | 41 | 3 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.00e-04 | 180 | 41 | 3 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.00e-04 | 180 | 41 | 3 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.00e-04 | 180 | 41 | 3 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.00e-04 | 180 | 41 | 3 | 05cce7e3c13dd3e3b70aaad841097be51cfadad3 | |
| ToppCell | MS|World / Condition, Cell_class and T cell subcluster | 6.10e-04 | 181 | 41 | 3 | 99f054a586a95947528dc3fd8043c1bda5e74cc4 | |
| ToppCell | BL-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.10e-04 | 181 | 41 | 3 | e3add2412c9f8eddfb77e0fbcd66fe57b23ae513 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-04 | 182 | 41 | 3 | 09d0793245d3d77ab5fc384c0b62637f736da50b | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|normal_Lung / Location, Cell class and cell subclass | 6.20e-04 | 182 | 41 | 3 | 13c39228f76495deca6b948483bbde426b3e8c5b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-04 | 183 | 41 | 3 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-04 | 183 | 41 | 3 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.30e-04 | 183 | 41 | 3 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-04 | 184 | 41 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-04 | 184 | 41 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-04 | 184 | 41 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-04 | 184 | 41 | 3 | a12a6a481e78adc62da1904431f62b119f70b15f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.50e-04 | 185 | 41 | 3 | eeef122d64b48b950a4cf3948b64f4ffd9f3ebe0 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.50e-04 | 185 | 41 | 3 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.50e-04 | 185 | 41 | 3 | f60b39010b9210a5f18ccd113758512bd15d7eec | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.50e-04 | 185 | 41 | 3 | 115a74d0b9be580005d45d22d6e228801b2705e2 | |
| ToppCell | critical-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.50e-04 | 185 | 41 | 3 | 4a5d1d0a757f1f4fdb911be96ed90b52182c25f0 | |
| ToppCell | droplet-Mammary_Gland-nan-3m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 185 | 41 | 3 | 02a2cbae9238c6c1e80b9a52a575e3b22f0eebb4 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.50e-04 | 185 | 41 | 3 | 2d95713deaa05fb3372f4337ef156027e4d8ec8a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.60e-04 | 186 | 41 | 3 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 6.71e-04 | 187 | 41 | 3 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 6.71e-04 | 187 | 41 | 3 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.71e-04 | 187 | 41 | 3 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.71e-04 | 187 | 41 | 3 | dda43cc4983f1c11a2258bbce9f805db4125322c | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.92e-04 | 189 | 41 | 3 | 24519fa45e7d1c2fb397e9ffe00ecb7f7d4cefd8 | |
| ToppCell | COVID-19-lung-Plasmablasts|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.92e-04 | 189 | 41 | 3 | fdf6c945b352614885e646a5ef4bc576dee73895 | |
| ToppCell | COPD|World / Disease state, Lineage and Cell class | 6.92e-04 | 189 | 41 | 3 | 53577632683686dc493a5a3fdc01887ec5c320f2 | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD4+_T|normal_Lung / Location, Cell class and cell subclass | 6.92e-04 | 189 | 41 | 3 | 4587d9b610e71698bb749fe1809c6210f93fecfc | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.02e-04 | 190 | 41 | 3 | b9182c84e44aa31684b5388cf3ef4fd1b9e51de4 | |
| Disease | Mental Retardation, Psychosocial | 3.07e-05 | 139 | 38 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 3.07e-05 | 139 | 38 | 4 | C0020796 | |
| Disease | Mental deficiency | 3.07e-05 | 139 | 38 | 4 | C0917816 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 8.82e-05 | 11 | 38 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.06e-04 | 71 | 38 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | Moyamoya Disease | 2.17e-04 | 17 | 38 | 2 | C0026654 | |
| Disease | fibrinogen measurement | 3.76e-04 | 109 | 38 | 3 | EFO_0004623 | |
| Disease | Glioblastoma Multiforme | 3.97e-04 | 111 | 38 | 3 | C1621958 | |
| Disease | osteoporosis (is_implicated_in) | 7.33e-04 | 31 | 38 | 2 | DOID:11476 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| INIKEHIRKGSIVVV | 511 | Q6PI77 | |
| VLHAQILEKDAVIKV | 631 | Q9Y2J4 | |
| SKAIIKLANIDIHVA | 241 | Q8N7X0 | |
| AVKIVKANKLDHVVT | 126 | Q99873 | |
| NIVEAVLHLAREVKK | 696 | Q8IZ41 | |
| LGVHEQKQEVVKFLI | 241 | H3BUK9 | |
| AVAHVVVKVIVEDQN | 2061 | Q14517 | |
| VHKVKASRDVIIDQL | 571 | O75197 | |
| LQKAVIDHTIKAIVI | 36 | Q08426 | |
| ARVDAKVEIIKHISA | 3541 | Q9Y6V0 | |
| VIVRAADCKKVHQIE | 1271 | Q9Y5S2 | |
| ALIVIEVHAKDVVSK | 1491 | Q9P2D7 | |
| THAVVIKKLNEILQA | 326 | B5ME19 | |
| ILKAQVEAVHKVTKE | 566 | Q9HCM4 | |
| VKEKVVALVHAVQAL | 176 | P24001 | |
| LAVFIKAVHVKAQED | 11 | P01591 | |
| AVKLKESVVENHAVL | 1916 | Q9C0D2 | |
| EVDLLKALKHVNIVA | 1111 | Q56UN5 | |
| GVVVLHKDVNVVVVE | 571 | O43395 | |
| LVTEHAQLVQIIKKT | 436 | Q07869 | |
| QKAKVKHSAIAVVVI | 236 | Q9UNW8 | |
| KRHTLEKNVLVVSVV | 86 | P06865 | |
| LVKAVNIAVDLIVAH | 996 | Q8N2Y8 | |
| AKKANVVALVAVAEH | 31 | Q17R31 | |
| TVTLVEAIKQVVKHL | 531 | Q9HCE1 | |
| LVENKKAQLVVIAHD | 146 | P62424 | |
| KIVFGKQLIENVHEV | 1341 | Q8IZX4 | |
| LGVHEQKQEVVKFLI | 241 | A0A0A6YYL3 | |
| LVFIVDVKANKHQIK | 96 | P62750 | |
| FQVVAKHVLEVKVVP | 636 | Q92854 | |
| AEIAINVHLDTLKKV | 466 | Q16281 | |
| QAVHAAKVILQVKES | 1351 | Q63HN8 | |
| VNVVKVGHKQVVALI | 636 | Q9BYB0 | |
| HIEVIVKARQKVKNT | 201 | Q9Y5W7 | |
| TSVVKKIHIEVVDKA | 136 | Q07699 | |
| VKVHVVDLKAESVAA | 716 | Q96K76 | |
| VHAIQIKTKLCQLVE | 1006 | P21359 | |
| EVDAAVIKVLSAKHN | 2151 | O43149 | |
| SLFVKKVQDVHAVEI | 86 | Q2M3R5 | |
| AQTLQVLEKHKADVV | 51 | Q9BZH6 | |
| KEIVQKLQGHTDVVI | 291 | P61964 | |
| VHVKSEVLAVKLSQE | 4346 | Q5THJ4 |